MLL3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.098000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.254380E-01
Normal-vs-Stage2
1.804330E-03
Normal-vs-Stage3
2.020100E-02
Normal-vs-Stage4
2.102200E-01
Stage1-vs-Stage2
2.871200E-01
Stage1-vs-Stage3
4.668300E-02
Stage1-vs-Stage4
7.243200E-01
Stage2-vs-Stage3
8.492300E-02
Stage2-vs-Stage4
7.730800E-01
Stage3-vs-Stage4
2.811600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.816700E-03
Normal-vs-AfricanAmerican
1.306570E-01
Normal-vs-Asian
3.714300E-02
Caucasian-vs-AfricanAmerican
5.001000E-01
Caucasian-vs-Asian
3.989000E-01
AfricanAmerican-vs-Asian
4.036400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.680900E-03
Normal-vs-Female
3.601600E-03
Male-vs-Female
8.604800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.749800E-01
Normal-vs-Age(41-60Yrs)
2.188300E-02
Normal-vs-Age(61-80Yrs)
1.641230E-03
Normal-vs-Age(81-100Yrs)
1.285360E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.648400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.240200E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.104290E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.123900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.038100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.469400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.881900E-03
Normal-vs-Daily Drinker
5.902800E-03
Normal-vs-Weekly Drinker
3.989700E-02
Normal-vs-Occasional Drinker
3.299800E-03
Normal-vs-Social Drinker
1.167230E-01
Non Drinker-vs-Daily Drinker
7.778400E-01
Non Drinker-vs-Weekly Drinker
9.328200E-01
Non Drinker-vs-Occasional Drinker
7.895800E-01
Non Drinker-vs-Social Drinker
1.718820E-01
Daily Drinker-vs-Weekly Drinker
7.655400E-01
Daily Drinker-vs-Occasional Drinker
9.902800E-01
Daily Drinker-vs-Social Drinker
1.287800E-01
Weekly Drinker-vs-Occasional Drinker
7.699800E-01
Weekly Drinker-vs-Social Drinker
3.279200E-01
Occasional Drinker-vs-Social Drinker
1.297640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.318850E-01
Normal-vs-Grade 2
2.481700E-02
Normal-vs-Grade 3
3.196200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.884800E-01
Grade 1-vs-Grade 3
7.001000E-01
Grade 1-vs-Grade 4
1.318850E-01
Grade 2-vs-Grade 3
4.211200E-01
Grade 2-vs-Grade 4
2.481700E-02
Grade 3-vs-Grade 4
3.196200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.035600E-03
Normal-vs-NonDiabetic
2.057600E-03
Diabetic-vs-NonDiabetic
7.690400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.757300E-03
Normal-vs-NoPancreatitis
2.576900E-03
Pancreatitis-vs-NoPancreatitis
6.922400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.582100E-03
Normal-vs-N1
2.461600E-03
N0-vs-N1
6.876800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.159600E-01
Normal-vs-TP53-NonMutant
7.214300E-02
TP53-Mutant-vs-TP53-NonMutant
8.582300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
